Robert C. Malenka, Director at MapLight Therapeutics, Inc. (MPLT), sold 8,593 shares at $26.90 ($231K) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Scheduled sale ($231k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MPLT | SELL | 2026-02-12 | $124K | — | Filing → |
| MPLT | SELL | 2026-02-04 | $127K | — | Filing → |
| MPLT | SELL | 2026-01-30 | $636K | — | Filing → |